We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





UV-C LED Disinfection Robot Exterminates 99.9% of Live Human Coronavirus in Five Minutes

By HospiMedica International staff writers
Posted on 26 Aug 2020
A UV-C LED disinfection robot that was tested in the laboratory using high concentrations of live samples of human coronavirus has achieved a 99.9% efficacy for disinfection within five minutes at a working distance of 2.5 meters.

O-RX, the world's first successfully laboratory tested human coronavirus exterminating machine, uses OTSAW’s (Singapore) patented UV-C LED. More...
O-RX is also the world’s first UV-C LED autonomous disinfection robot with a disinfection rate of 99.9%. Its innovative UV-C LED technology emits only UV-C light, which is effective in killing microbes, including viruses such as COVID-19. Using UV-C LED technology makes O-RX 70% more energy efficient as compared to conventional mercury lamps. In addition, it is friendly to humans as it is much safer and non-cancerous to human skin as compared to conventional mercury lamps that emit harmful UV-A and UV-B radiation.

O-RX has a battery that lasts for five hours and is equipped with a state-of-the-art heat management and cooling system to help counter the heat that is emitted from the high intensity LED modules in the robot. The disinfection robot can disinfect 4,000 square feet (371.6 square meters) hourly.

"The world has gone through drastic changes and is delicately poised socially and economically for changes ahead. OTSAW and the O-RX are now part of this new world as we restart and focus to unite humanity and beat this virus," said Ling Ting Ming, CEO/Founder of OTSAW.

Related Links:
OTSAW


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.